Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT00122993 Completed - Obesity Clinical Trials

Worksite Program to Prevent Weight Gain Among Bus Drivers

Start date: September 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to implement and evaluate a two-year multi-component environmental intervention to prevent weight gain among city bus drivers at four bus garages. It is hypothesized that transit employees in the intervention garages will gain less weight compared to the transit employees in the control garages.

NCT ID: NCT00122928 Completed - Obesity Clinical Trials

Comparison of Workplace Obesity Management Programs

Start date: October 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to design and demonstrate the feasibility of implementing moderate and intensive environmental obesity prevention programs at major worksites.

NCT ID: NCT00122447 Completed - Clinical trials for Impaired Glucose Tolerance

Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance

Start date: May 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether cardiovascular disease (CVD) risk markers, β-cell function, and insulin sensitivity can be improved by targeting mechanisms of both diabetes and CVD - using an antioxidant, an angiotensin II receptor blocker (ARB), or an anti-inflammatory agent - in patients with impaired glucose tolerance (IGT) in a randomized, controlled trial.

NCT ID: NCT00121550 Completed - Clinical trials for Cardiovascular Disease

The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease

Start date: October 1999
Phase: Phase 3
Study type: Interventional

A growing body of evidence links Chlamydia pneumoniae to the progression of coronary heart disease. The purpose of this study is to determine the positive and negative effect of 14 days treatment with clarithromycin 500 mg daily in patients already suffering from stable coronary heart disease. The participants will be followed for at least two years after the treatment. Abbott Laboratories supplied Clarithromycin and placebo tablets.

NCT ID: NCT00120107 Completed - Clinical trials for Cardiovascular Disease

Tea's Effect on Atherosclerosis Pilot Study (TEA Study)

Start date: July 2003
Phase: N/A
Study type: Interventional

The researchers propose a pilot study of the effect of long-term tea intake on atherosclerosis. Thirty patients at high risk for cardiovascular disease will be recruited and randomized to a six-month period of consumption of 3 cups per day of either tea, supplied as black tea solids readily dissolved in hot or cold liquid, or water. At baseline and after 6 months, atherosclerosis in the aorta will be assessed using magnetic resonance imaging. The primary outcomes of this pilot study will be compliance with tea intake and 2 MRI examinations. As secondary outcomes, standard and novel cardiovascular risk markers, including inflammatory, prothrombotic, fibrinolytic, vascular and metabolic factors will be measured. If successful, this pilot study will form the basis for a larger, long-term randomized trial to determine the effect of tea consumption on progression of atherosclerosis.

NCT ID: NCT00119847 Completed - Clinical trials for Cardiovascular Diseases

Electrophysiological Effects of Late PCI After MI

Start date: September 2002
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if opening blocked arteries with heart balloons and stents prevents heart rhythm problems in individuals 3 to 28 days after a heart attack.

NCT ID: NCT00119834 Completed - Clinical trials for Cardiovascular Diseases

Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs)

Start date: June 2005
Phase:
Study type: Observational

The Intermacs registry is a national quality improvement system designed to advance the understanding and application of mechanical circulatory support in order to improve the duration and quality of life in patients with advanced heart failure.

NCT ID: NCT00119821 Completed - Obesity Clinical Trials

Strategies to Reduce Weight Gain in Hypertensive Smokers

Start date: September 2004
Phase: N/A
Study type: Interventional

To evaluate the effectiveness of lifestyle modification following a smoking cessation program in preventing weight gain among hypertensive smokers placed at medical risk by the post-cessation weight gain.

NCT ID: NCT00119795 Completed - Obesity Clinical Trials

Exercise and Weight Loss for Improving Mobility in Older Adults Who Are Obese

CLIP
Start date: August 2005
Phase: N/A
Study type: Interventional

To test the effects of exercise and weight loss on mobility disability of older overweight/obese men and women who have evidence of cardiovascular disease or the metabolic syndrome.

NCT ID: NCT00119782 Completed - Obesity Clinical Trials

Promoting Activity and Changes in Eating (PACE) to Reduce Obesity

PACE
Start date: September 2004
Phase: N/A
Study type: Interventional

Reducing the prevalence of obesity in the population is one of the Healthy People 2010 goals. Increased vigilance is required in all age groups in preventing and reversing overweight and obesity. On an individual level, behavioral factors that influence body weight include eating choices leading to excess calorie intake and physical activity patterns leading to diminished calorie expenditure. An imbalance between the two over time leads to increased weight. On a population basis, the prevalence of overweight is associated with a myriad of influences, including social, behavioral, cultural, and environmental factors as well as genetic and physiological factors. For a majority of overweight individuals, restoring a balance between energy intake and expenditure is difficult, and therefore there is an increasing emphasis on preventing obesity on a population level. The long-term goal of this research is to prevent further increase in rates of obesity in the population. In the adult population of working age, a majority of the day is spent in the worksite, suggesting that interventions at the worksite level may offer the opportunity for success in this age group. It is anticipated that this project will yield important contributions to the understanding of obesity prevention.